팔로우
Janice Reichert
Janice Reichert
The Antibody Society
reichertbiotechconsulting.com의 이메일 확인됨
제목
인용
인용
연도
Development trends for human monoclonal antibody therapeutics
AL Nelson, E Dhimolea, JM Reichert
Nature reviews drug discovery 9 (10), 767-774, 2010
13222010
Bispecific antibodies: a mechanistic review of the pipeline
AF Labrijn, ML Janmaat, JM Reichert, PWHI Parren
Nature reviews Drug discovery 18 (8), 585-608, 2019
11192019
Monoclonal antibody successes in the clinic
JM Reichert, CJ Rosensweig, LB Faden, MC Dewitz
Nature biotechnology 23 (9), 1073-1078, 2005
10992005
Future directions for peptide therapeutics development
AA Kaspar, JM Reichert
Drug discovery today 18 (17-18), 807-817, 2013
8862013
Development trends for monoclonal antibody cancer therapeutics
JM Reichert, VE Valge-Archer
Nature Reviews Drug Discovery 6 (5), 349-356, 2007
5462007
Antibodies to watch in 2019
H Kaplon, JM Reichert
MAbs 11 (2), 219-238, 2019
4772019
Marketed therapeutic antibodies compendium
JM Reichert
MAbs 4 (3), 413-415, 2012
4632012
Recombinant protein therapeutics—success rates, market trends and values to 2010
AK Pavlou, JM Reichert
Nature biotechnology 22 (12), 1513-1519, 2004
4632004
Antibodies to watch in 2020
H Kaplon, M Muralidharan, Z Schneider, JM Reichert
MAbs 12 (1), 1703531, 2020
4502020
Development trends for therapeutic antibody fragments
AL Nelson, JM Reichert
Nature biotechnology 27 (4), 331-337, 2009
4142009
Antibodies to watch in 2013: Mid-year update
JM Reichert
MAbs 5 (4), 513-517, 2013
397*2013
Antibody–drug conjugates come of age in oncology
C Dumontet, JM Reichert, PD Senter, JM Lambert, A Beck
Nature reviews Drug discovery 22 (8), 641-661, 2023
3512023
Trends in development and approval times for new therapeutics in the United States
JM Reichert
Nature reviews Drug discovery 2 (9), 695-702, 2003
3372003
Monoclonal antibodies as innovative therapeutics
JM Reichert
Current pharmaceutical biotechnology 9 (6), 423-430, 2008
3272008
Antibodies to watch in 2022
H Kaplon, A Chenoweth, S Crescioli, JM Reichert
MAbs 14 (1), 2014296, 2022
3162022
Antibody-based therapeutics to watch in 2011
JM Reichert
MAbs 3 (1), 76-99, 2011
3142011
Antibodies to watch in 2017
JM Reichert
MAbs 9 (2), 167-181, 2017
3122017
Antibodies to watch in 2021
H Kaplon, JM Reichert
MAbs 13 (1), 1860476, 2021
3112021
Monoclonal antibodies in the clinic
JM Reichert
Nature biotechnology 19 (9), 819-822, 2001
3062001
Antibodies to watch in 2018
H Kaplon, JM Reichert
MAbs 10 (2), 183-203, 2018
2832018
현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.
학술자료 1–20